Guillain-Barre syndrome: Guillain-BarrC) syndrome (GBS) is the term used to describe a spectrum of rare post-infectious neuropathies that usually occur in otherwise healthy patients. GBS is clinically heterogeneous and encompasses acute inflammatory demyelinating polyradiculoneuropathy (AIDP), acute motor axonal neuropathy (AMAN) and acute motor-sensory axonal neuropathy (AMSAN), Miller-Fisher syndrome (MFS; see these terms) and some other regional variants.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
573 |
4. Check minimum number of eventsNone |
573 |
5. Include endpointsNone |
573 |
6. Filter based on genotype QC (FinnGen only) |
573 |
Control definitions (FinnGen only)
- Control exclude
- G6_POLYNEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G61
- Name in latin
- Syndroma Guillain-Barré
Similar endpoints
↥List of similar endpoints to
Guillain-Barre syndrome
based on the number of shared cases.
Similar with more cases:
- Polyneuropathies and other disorders of the peripheral nervous system
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Neurological diseases
- Neurological diseases, wide definition
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4635 | 2063 | 2535 |
| Only index persons | 3894 | 1777 | 2117 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.06 | 0.07 |
| Only index persons | 0.07 | 0.07 | 0.08 |
| Median age at first event (years) | |||
| Whole population | 50.92 | 49.00 | 52.39 |
| Only index persons | 48.14 | 46.19 | 49.78 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 573 | 265 | 308 |
| Unadjusted period prevalence (%) | 0.11 | 0.09 | 0.14 |
| Median age at first event (years) | 52.11 | 48.41 | 55.29 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 510
- Matched controls
- 5102
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G61.0
ICD-10 Finland
Guillain-Barré syndrome
+∞
323.0
425
*
TAB00
NOMESCO Finland
Lumbar puncture
15.2
69.4
120
101
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
62.0
68.3
79
15
G61.9
ICD-10 Finland
Inflammatory polyneuropathy, unspecified
+∞
55.2
52
*
35401
ICD-8 Finland
Polyneuritis and polyradiculitis, Polyradicultitis Guillain-Barré
+∞
53.0
50
*
3570A
ICD-9 Finland
Inflammatory and toxic neuropathy, Acute infective polyneuritis
+∞
48.7
46
*
G61.8
ICD-10 Finland
Other inflammatory polyneuropathies
+∞
45.5
43
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
23.5
37.0
53
25
6BA02
NOMESCO Finland
NA
82.1
34.3
38
5
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.8
32.5
99
202
N03AX12
ATC
gabapentin; oral
4.1
28.5
127
384
WW400
NOMESCO Finland
Plasmaferesis
285.3
27.0
27
*
R20.2
ICD-10 Finland
Paraesthesia of skin
5.6
25.2
78
160
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
27.9
25.2
34
13
ZX120
NOMESCO Finland
Intravenous
4.2
22.3
91
249
G62.8
ICD-10 Finland
Other specified polyneuropathies
+∞
22.0
21
*
N99
ICPC
Neurological disease other
27.8
21.6
29
11
R4120
NOMESCO Finland
Occupational therapy
5.5
20.8
64
130
N03AX16
ATC
pregabalin; oral
2.8
20.3
157
695
N28
ICPC
Limited function/disability (N)
13.9
17.2
29
22
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.9
17.0
74
213
G82.2
ICD-10 Finland
Paraplegia, unspecified
31.2
16.2
21
7
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.5
14.9
54
131
N29
ICPC
Neurological sympt/complt other
9.0
14.4
30
35
AA1AD
NOMESCO Finland
CT of head and brain
2.4
14.1
148
753
N94
ICPC
Peripheral neuritis/neuropathy
+∞
13.6
13
*
G35
ICD-10 Finland
Multiple sclerosis
12.6
13.2
23
19
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.6
13.0
101
435
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
13.0
103
447
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
9.6
12.1
24
26
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
8.7
11.9
25
30
R1250
NOMESCO Finland
Evaluation of functional capability
8.1
11.0
24
31
G51.0
ICD-10 Finland
Bell palsy
6.1
10.9
29
50
N18
ICPC
Paralysis/weakness
8.1
9.7
21
27
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.9
9.7
59
218
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
5.9
9.6
26
46
L28
ICPC
Limited function/disability (L)
2.4
9.6
89
419
R4110
NOMESCO Finland
Physiotherapy
2.0
9.1
140
818
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.9
8.7
27
57
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.2
8.6
44
145
H02AB06
ATC
prednisolone; systemic
1.8
8.6
237
1685
N06AA09
ATC
amitriptyline; systemic
2.8
8.5
56
217
N06AX21
ATC
duloxetine; oral
2.6
8.4
60
246
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
8.2
115
648
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
8.0
217
1524
GBB00
NOMESCO Finland
Tracheostomy
9.6
7.8
15
16
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
45.7
7.7
9
*
2AB04
NOMESCO Finland
NA
45.7
7.7
9
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
7.7
85
432
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
7.7
78
381
H02AB07
ATC
prednisone; oral
2.2
7.5
77
377
G60.0
ICD-10 Finland
Hereditary motor and sensory neuropathy
81.2
7.4
8
*
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
13.6
7.4
12
9
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
13.6
7.4
12
9
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.5
7.4
57
243
L04AX01
ATC
azathioprine; systemic
3.6
7.4
32
94
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
+∞
7.3
7
*
M48.0
ICD-10 Finland
Spinal stenosis
2.3
7.2
64
294
XA402
NOMESCO Finland
ENMG
5.2
7.2
21
42
109
Kela drug reimbursment
Multiple sclerosis
9.0
7.1
14
16
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.4
7.0
33
103
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
14.0
6.9
11
8
A28
ICPC
Limited function/disability NOS
2.2
6.9
73
364
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
11.1
6.8
12
11
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
9.5
6.8
13
14
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.5
6.8
50
209
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.3
6.7
19
37
R53
ICD-10 Finland
Malaise and fatigue
1.9
6.5
99
572
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
6.5
43
170
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
9.4
6.3
12
13
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
9.4
6.3
12
13
G61
ICD-10 Finland
Inflammatory polyneuropathy
+∞
6.3
6
*
NA7DM
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with 3 Tesla magnet
+∞
6.3
6
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.9
6.1
35
125
N03AE01
ATC
clonazepam; systemic
3.0
6.1
32
110
C03CA01
ATC
furosemide; systemic
1.7
6.1
135
878
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
6.0
139
913
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
129
95
17.23
143.72
1.3
1.2
mmol/l
3.9
3.7
0.47
124
87
(3044290) Cell count panel - Cerebral spinal fluid
120
83
18.02
138.05
1.5
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
87
44
23.13
115.42
1.2
1.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
112
99
13.82
111.26
1.4
1.2
e6/l
10.0
9.8
0.01
92
78
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
112
99
13.82
111.26
1.5
1.3
e6/l
492.0
1203.5
0.28
93
82
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
87
50
20.34
108.93
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
86
50
20.06
107.06
1.2
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
70
36
22.01
91.76
1.3
1.1
mg/l
75.5
41.7
1.70
62
30
(3016018) Differential panel - Cerebral spinal fluid
66
33
22.47
87.47
1.4
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
62
32
21.60
80.95
1.2
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
68
44
17.40
79.85
1.5
1.3
—
—
—
0
0
(4027681)
51
30
18.56
62.47
1.5
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
53
37
15.68
59.48
1.1
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
44
21
22.61
59.03
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
46
27
18.44
56.30
1.2
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
45
26
18.70
55.47
1.1
1.0
u/l
1.0
1.2
0.50
25
13
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
35
15
24.79
48.80
1.3
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
127
360
4.25
40.76
2.6
2.3
g/l
10.4
10.6
0.20
115
332
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
29
18
16.92
34.25
1.3
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
33
28
12.44
32.78
1.1
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
110
358
3.57
28.34
2.5
2.9
g/l
67.2
66.8
0.18
101
328
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
255
1330
2.65
28.15
2.7
2.1
u/l
841.4
303.4
0.44
241
1250
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
24
15
16.66
28.14
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
24
15
16.66
28.14
1.1
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
24
15
16.66
28.14
1.1
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
197
905
2.79
27.95
1.6
1.4
g/l
2.3
2.5
1.02
152
573
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
23
14
17.07
27.30
1.1
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
95
289
3.74
27.01
2.1
2.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
40
59
7.21
26.22
1.3
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
22
14
16.30
25.51
1.1
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
17
13.42
22.96
1.1
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
51
113
4.86
21.93
1.1
1.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
24
7
35.69
19.03
1.3
1.0
mg/g
19.7
6.0
—
24
7
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
24
8
31.22
18.47
1.3
1.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
345
2360
2.16
17.58
8.4
6.1
e9/l
0.2
0.2
0.03
309
2092
(3001604) Monocytes [#/volume] in Blood
335
2271
2.14
17.41
8.1
5.7
e9/l
0.6
0.6
0.23
296
1974
(3006315) Basophils [#/volume] in Blood
335
2280
2.13
17.12
8.2
5.7
e9/l
0.0
0.0
0.53
295
1990
(3019198) Lymphocytes [#/volume] in Blood
339
2339
2.10
16.44
8.2
5.8
e9/l
1.8
2.0
1.05
304
2084
(3028679) Herpes simplex virus Ab [Presence] in Serum
19
20
9.79
16.19
1.1
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
11
13.98
15.97
1.1
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
143
716
2.33
15.71
3.9
3.4
mmol/l
0.8
0.8
0.57
136
681
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
151
3.69
15.62
2.4
2.5
g/l
3.0
3.2
0.86
42
120
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
147
3.71
15.49
1.8
2.6
g/l
10.4
10.6
0.05
43
127
(3022096) Basophils/100 leukocytes in Blood
307
2079
2.03
15.24
8.6
5.8
%
0.7
0.7
0.05
288
1957
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
160
3.55
15.03
2.4
2.5
g/l
3.4
3.8
1.80
41
118
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
160
3.55
15.03
2.4
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
160
3.55
15.03
2.4
2.5
g/l
7.4
7.4
0.10
41
123
(42870588) Differential panel, method unspecified - Blood
244
1529
2.04
14.98
8.0
5.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
312
2140
2.01
14.77
8.6
5.8
%
2.9
2.9
0.20
294
2010
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
60
199
3.25
14.68
1.9
2.1
u/l
32.4
39.2
1.66
55
178
(3037522) Nuclear Ab [Titer] in Serum
123
596
2.35
14.47
1.4
1.3
titre
460.0
441.6
0.05
24
129
(3019069) Monocytes/100 leukocytes in Blood
312
2155
1.98
14.31
8.9
6.1
%
8.8
8.7
0.19
296
2038
(3006653) Thiamine [Moles/volume] in Blood
18
21
8.82
14.20
1.0
1.4
nmol/l
130.9
159.2
0.94
18
21
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
19
24
8.15
14.09
2.8
2.1
%
9.7
12.8
—
9
11
(3002030) Lymphocytes/100 leukocytes in Blood
318
2220
1.97
14.04
8.7
5.9
%
27.4
27.8
0.23
301
2092
(3014148) Varicella zoster virus Ab [Titer] in Serum
28
54
5.40
14.04
1.3
1.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
313
2181
1.96
13.82
8.5
5.7
%
58.0
57.1
0.61
297
2063
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
45
133
3.59
13.16
1.9
2.6
g/l
38.3
37.4
0.37
40
115
(3013650) Neutrophils [#/volume] in Blood by Automated count
360
2666
1.94
12.87
12.0
9.2
e9/l
4.1
4.1
0.04
323
2338
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
17
21
8.31
12.81
1.1
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
17
21
8.31
12.81
3.0
2.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
16
5
32.85
12.63
1.3
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
360
2682
1.92
12.46
7.1
4.7
mmol/l
6.7
6.7
0.13
345
2506
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
46
146
3.34
12.06
2.0
2.8
g/l
0.3
1.0
1.13
41
130
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
5
30.74
11.69
1.1
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
141
781
2.07
11.68
1.8
1.7
nmol/l
1127.6
1164.1
0.19
113
604
(3011412) CD3 cells [#/volume] in Blood
22
41
5.54
11.43
3.0
2.0
e9/l
1.2
1.2
0.00
16
16
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
37
108
3.59
11.03
1.1
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
110
580
2.11
10.28
7.7
5.8
mmol/l
1.0
1.0
0.10
103
538
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
36
109
3.46
10.16
1.2
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
272
1939
1.77
10.02
6.4
4.8
g/l
34.3
35.7
3.16
255
1811
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
23
51
4.66
9.85
1.2
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
68
299
2.45
9.77
2.3
1.6
g/l
2.1
1.6
0.28
63
275
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
252
1771
1.75
9.65
2.3
1.9
pmol/l
91.7
95.1
0.47
150
939
(3020779) Urea [Moles/volume] in Serum or Plasma
82
394
2.26
9.64
7.4
6.9
mmol/l
9.6
9.7
0.04
77
376
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
299
2206
1.74
9.63
9.4
6.7
mmol/l
1.2
1.2
0.08
253
1871
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
14
8
17.90
9.44
1.2
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
32
95
3.51
9.31
1.6
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
277
2018
1.72
9.19
9.0
5.9
mmol/l
1.2
1.2
0.39
254
1836
(3031040) Bacteria [#/volume] in Urine by Automated count
376
2986
1.75
9.07
6.2
4.3
e6/l
73.2
1890.8
—
10
51
(3007853) Bacteria identified in Skin by Aerobe culture
98
520
2.07
8.94
2.1
1.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
31
94
3.43
8.74
6.3
6.7
iu/ml
1699.1
209.6
—
8
14
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
158
994
1.81
8.66
2.1
1.7
mg/l
1.6
1.2
0.56
128
764
(3026782) Osmolality of Urine
146
899
1.84
8.57
3.7
2.6
mosm/kgh2o
532.9
571.2
1.34
129
764
(21494814) CD8 cells/100 lymphocytes in Specimen
10
11
9.23
8.11
2.9
2.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
163
1054
1.76
8.07
1.7
1.5
nmol/l
20.2
20.8
0.20
139
901
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
233
1666
1.67
7.96
5.0
3.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
149
951
1.77
7.67
3.7
2.4
e6/l
4.7
4.7
0.01
138
840
(3028433) Virus identified in Specimen by Culture
12
18
6.79
7.63
1.3
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
6
18.65
7.62
1.2
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
165
1086
1.73
7.61
2.3
2.1
mg/l
3.1
3.1
0.03
128
927
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
24
68
3.64
7.49
2.6
4.0
—
3459.6
—
0
8
(3015171) Extractable nuclear Ab [Units/volume] in Serum
41
164
2.62
7.18
1.3
1.3
u/ml
5.1
2.3
—
5
12
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
241
1774
1.62
7.14
2.6
2.3
nmol/l
76.5
76.3
0.03
219
1592
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
37
141
2.74
7.11
2.7
2.4
u/ml
0.3
0.3
0.44
18
70
(3036481) Cortisol [Moles/volume] in Serum or Plasma
77
406
2.04
7.10
2.5
2.0
nmol/l
323.7
378.7
2.03
69
376
(36304419) Bacteria [Presence] in Urine
180
1235
1.67
7.03
4.6
3.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
90
504
1.93
6.99
3.2
2.7
%
2.0
1.8
0.58
79
465
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
11
17
6.58
6.80
1.1
1.0
miu/ml
1465.1
1433.5
0.03
11
17
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
25
78
3.31
6.77
1.6
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
186
1308
1.62
6.51
3.8
2.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
187
1320
1.62
6.43
5.1
4.1
ph
7.4
7.4
1.64
36
244
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
45
200
2.36
6.33
1.6
2.2
g/l
1.6
1.5
0.24
40
174
(3000991) Gas panel - Venous blood
69
365
2.01
6.30
11.2
8.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
196
1409
1.59
6.21
4.8
3.1
e6/l
33.2
115.2
1.04
162
1089
(3021879) Hepatitis B virus core Ab [Presence] in Serum
67
354
2.01
6.14
1.4
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
401
3398
1.60
6.10
5.0
4.0
mm/h
13.8
11.8
1.83
373
3132
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
25
84
3.07
6.03
1.3
1.3
u/ml
44.9
33.0
—
5
9
(3030467) Casts [#/volume] in Urine by Automated count
179
1268
1.60
6.00
4.8
3.0
e6/l
0.3
0.6
1.04
145
946
(3023368) Bacteria identified in Blood by Culture
178
1260
1.60
5.98
5.9
4.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
219
1636
1.55
5.79
5.3
3.7
e6/l
47.7
131.2
1.79
169
1169
(3037467) Urinalysis macro (dipstick) panel - Urine
375
3147
1.55
5.78
6.3
4.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
303
2431
1.52
5.73
6.8
6.4
umol/l
11.1
11.8
0.63
293
2328
(3032080) INR in Blood by Coagulation assay
242
1859
1.52
5.57
7.7
8.7
inr
1.1
1.2
0.96
70
541
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
17
47
3.70
5.52
1.3
1.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
72
409
1.87
5.34
4.9
3.6
mmol/l
1.7
1.9
0.21
61
325
(3001122) Ferritin [Mass/volume] in Serum or Plasma
249
1941
1.50
5.26
3.0
2.7
ug/l
283.9
134.7
0.68
224
1802
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
35
153
2.37
5.14
1.2
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
32
137
2.41
4.92
1.4
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
78
2.89
4.87
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
78
2.89
4.87
1.3
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
12
28
4.36
4.84
1.3
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
407
3541
1.52
4.79
9.5
7.7
u/l
77.6
78.6
0.15
386
3339
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
32
139
2.38
4.77
1.5
1.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
38
179
2.20
4.71
1.3
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
88
553
1.70
4.64
1.7
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
92
2.68
4.62
1.1
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
23
87
2.71
4.54
1.1
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
8
10.12
4.53
3.3
1.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
59
332
1.87
4.52
1.9
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
52
281
1.94
4.49
5.2
3.8
mmol/l
2.3
1.7
0.72
41
208
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
111
751
1.59
4.38
2.3
1.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
12
7.60
4.37
1.3
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
123
855
1.56
4.32
2.0
1.9
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
9
8.99
4.29
1.0
1.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
64
376
1.79
4.27
3.6
2.8
e9/l
74.4
70.9
0.27
53
298
(40758558) Short blood count panel - Blood
155
1145
1.48
4.08
10.7
7.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
111
764
1.56
4.06
1.3
1.3
iu/ml
37.7
37.9
0.00
25
241
(3019832) Treponema pallidum Ab [Presence] in Serum
70
429
1.72
4.05
1.6
1.7
—
—
—
0
0
(3009343) pH of Capillary blood
53
299
1.85
4.04
5.3
3.7
ph
7.4
7.4
—
6
31
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
112
774
1.56
4.02
4.0
2.8
e6/l
1.1
0.9
0.28
70
440
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
150
1112
1.47
3.85
3.2
2.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
82
533
1.63
3.80
11.5
7.5
mmol/l
1.8
1.0
1.08
67
423
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
5
12.11
3.77
3.8
5.8
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
42
225
1.94
3.75
12.8
10.7
mmol/l
24.9
24.4
0.54
37
214
(3025941) Bacteria identified in Stool by Culture
45
247
1.89
3.74
1.3
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
80
519
1.63
3.74
2.3
1.8
—
—
—
0
0
(3019225) pH of Specimen
68
424
1.69
3.70
5.0
4.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
26
116
2.30
3.70
1.5
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
99
678
1.56
3.69
3.1
2.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
136
2.19
3.67
1.3
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
29
136
2.19
3.67
2.8
4.5
mg/l
32.4
34.9
0.14
23
114
(3034860) Kappa light chains.free [Mass/volume] in Serum
29
136
2.19
3.67
2.8
4.5
mg/l
36.1
105.8
0.87
23
112
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
7
9
7.86
3.56
1.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
46
3.09
3.55
1.1
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
41
3.22
3.51
1.2
1.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
80
531
1.59
3.41
11.8
7.5
kpa
5.2
5.1
0.56
75
510
(3027801) Oxygen [Partial pressure] in Arterial blood
80
532
1.59
3.38
11.8
7.5
kpa
11.4
12.1
0.85
74
514
(1616796) Gas panel - Central venous blood
22
95
2.37
3.38
6.7
2.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
126
925
1.46
3.37
1.9
1.7
pmol/l
446.2
428.8
0.25
105
791
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
34
176
1.99
3.36
1.8
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
68
436
1.63
3.34
1.7
2.2
g/l
0.2
0.2
0.03
60
412
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
133
989
1.45
3.32
1.3
1.2
u/ml
0.6
2.0
2.29
29
275
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
90
2.38
3.28
1.4
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
185
1464
1.39
3.25
3.5
2.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
22
97
2.32
3.23
3.0
4.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
38
3.20
3.23
2.0
3.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
100
707
1.50
3.21
1.8
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
245
2034
1.36
3.18
15.0
9.2
e9/l
0.0
0.0
0.28
200
1679
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
78
524
1.57
3.16
2.2
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
63
403
1.63
3.13
2.7
2.2
nmol/l
12.3
13.6
0.63
57
365
(3020876) Protein [Mass/time] in 24 hour Urine
12
39
3.12
3.10
1.2
2.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
11
34
3.28
3.07
1.1
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
100
714
1.49
3.06
2.5
2.3
umol/l
12.2
13.2
0.71
93
659
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
27
133
2.08
3.06
1.4
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
8
7.56
3.06
1.0
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
264
2227
1.34
3.05
4.7
3.5
estimate
0.0
0.0
0.00
51
431
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
25
121
2.11
2.97
1.5
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
168
1326
1.38
2.96
4.4
3.2
mg/l
1375.6
253.3
1.00
115
870
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
24
115
2.13
2.92
1.6
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
185
1486
1.36
2.92
3.2
3.4
mmol/l
2.3
2.3
1.20
162
1306
(3004789) Transferrin [Mass/volume] in Serum or Plasma
92
654
1.48
2.88
2.3
2.3
g/l
2.3
2.3
0.08
86
607
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
381
3412
1.35
2.85
3.9
3.8
pmol/l
14.7
14.7
0.21
342
3096
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
18
77
2.38
2.84
1.4
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
11
36
3.10
2.82
1.1
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
18
4.49
2.80
1.5
1.7
umol/l
25.9
28.6
—
8
18
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
118
886
1.42
2.77
4.4
3.8
ng/l
372.5
314.2
0.08
91
685
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
12
42
2.90
2.76
2.5
2.0
e6/l
1076.4
782.9
—
5
20
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
27
139
1.99
2.75
1.8
1.6
iu/ml
0.3
0.1
—
7
26
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
68
458
1.55
2.74
4.8
3.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
7
14
5.05
2.73
1.0
1.0
%
127.9
138.8
—
7
14
(4146454)
13
48
2.75
2.73
3.6
2.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
101
741
1.44
2.69
4.3
3.0
e6/l
4.1
1.8
0.81
59
409
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
65
436
1.55
2.67
3.5
2.5
u/l
59.1
33.0
0.44
59
374
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
16
67
2.43
2.65
1.4
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
31
170
1.87
2.64
1.2
1.3
iu/l
38.1
24.4
0.78
24
145
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
350
3114
1.32
2.63
4.0
3.2
u/l
54.5
48.9
0.56
325
2936
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
17
74
2.34
2.60
1.1
1.1
iu/ml
6.3
18.7
—
8
18
(3017732) Neutrophils [#/volume] in Blood
50
317
1.63
2.60
2.4
2.5
e9/l
4.0
4.0
0.02
34
253
(3022313) Gas panel - Capillary blood
38
224
1.75
2.57
6.1
3.9
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
20
4.04
2.57
1.1
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
18
81
2.26
2.56
2.8
1.7
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
7
7.19
2.55
1.0
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
78
552
1.48
2.50
3.3
2.8
umol/l
11.8
8.6
0.29
66
479
(3025159) Blasts/100 leukocytes in Blood
52
337
1.60
2.48
5.9
4.2
%
0.0
0.2
1.03
17
93
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
211
1765
1.31
2.45
4.7
3.6
ng/l
30.0
35.6
0.49
144
1211
(3021601) Nitrite [Presence] in Urine by Test strip
261
2247
1.30
2.44
6.2
4.8
estimate
0.0
0.0
0.00
53
432
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
64
2.38
2.40
1.2
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
97
2.10
2.40
1.8
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
81
583
1.45
2.39
1.8
1.8
%
1.4
1.5
0.12
68
517
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
23
118
1.99
2.38
1.3
1.5
—
—
—
0
0
(44790047)
14
58
2.45
2.38
1.7
1.5
—
—
—
0
0
(44790048)
14
58
2.45
2.38
1.7
1.5
—
—
—
0
0
(44790049)
14
58
2.45
2.38
1.7
1.5
—
—
—
0
0
(44806118)
14
58
2.45
2.38
1.7
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
12
46
2.64
2.37
1.8
2.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
49
317
1.60
2.36
9.0
4.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
19
91
2.13
2.35
1.3
1.3
u/ml
245.3
257.8
0.08
13
51
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
84
614
1.43
2.29
2.4
2.4
%
22.7
23.4
0.17
72
534
(3035637) Corticotropin [Mass/volume] in Plasma
12
47
2.59
2.28
1.4
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
30
172
1.79
2.25
3.0
4.5
g/l
0.1
0.3
—
9
82
(3009261) Glucose [Presence] in Urine by Test strip
262
2274
1.28
2.25
4.8
3.5
estimate
0.0
0.0
0.50
53
417
(3003327) Ova and parasites identified in Stool by Light microscopy
27
150
1.84
2.24
2.1
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
76
548
1.45
2.23
4.8
4.5
%
32.3
31.8
0.10
51
376
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
9
5.59
2.21
1.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
9
5.59
2.21
1.0
2.9
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
9
5.59
2.21
1.0
1.0
%
88.0
96.4
—
5
9
(3026493) Urate [Moles/volume] in Serum or Plasma
147
1185
1.32
2.19
3.4
2.7
umol/l
2338.5
7384.8
1.31
125
1039
(4062490)
11
42
2.65
2.19
1.5
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
18
87
2.10
2.19
1.8
1.6
u/ml
91.7
111.7
—
7
14
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
19
3.72
2.15
1.1
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
37
230
1.65
2.11
1.6
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
178
1481
1.29
2.10
3.3
2.5
u/l
53.0
56.4
1.07
165
1385
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
25
3.23
2.10
1.4
2.7
u/ml
2270.0
907.5
—
8
25
(3021440) Promyelocytes/100 leukocytes in Blood
53
360
1.52
2.09
5.8
4.2
%
0.1
0.1
0.72
18
110
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
31
2.93
2.08
1.0
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
31
2.93
2.08
1.0
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
19
96
2.01
2.07
1.7
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
42
272
1.59
2.04
1.5
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
83
2.08
2.03
1.6
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
28
163
1.75
2.02
2.0
2.9
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
38
2.66
2.02
1.2
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
172
1435
1.28
1.97
4.5
3.2
mmol/l
7.3
7.9
1.24
139
1195
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
113
1.89
1.94
1.9
1.8
iu/l
7.3
6.8
—
7
35
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
39
2.59
1.93
1.2
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
55
384
1.48
1.92
5.7
4.1
%
0.2
0.9
3.60
18
123
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
249
2178
1.25
1.92
5.0
4.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
121
1.85
1.91
1.1
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
185
1564
1.27
1.90
3.6
3.2
u/l
30.3
32.5
0.73
173
1494
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
487
4620
1.36
1.89
23.6
13.9
mg/l
22.1
23.4
0.38
414
3691
(3051651) Icteric interference index of Serum or Plasma
9
34
2.67
1.87
3.4
3.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
444
4163
1.30
1.83
4.8
4.5
mu/l
1.8
2.2
0.69
406
3810
(3003129) Base excess in Capillary blood by calculation
5
12
4.19
1.82
1.8
1.1
mmol/l
0.9
2.5
—
5
12
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
35
2.60
1.80
1.0
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
127
1030
1.30
1.80
4.2
3.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
131
1.79
1.80
1.4
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
157
1309
1.27
1.80
3.2
3.1
ng/l
1719.7
1335.0
0.33
136
1127
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
47
2.37
1.78
1.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
210
1814
1.25
1.78
2.1
2.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
167
1405
1.27
1.77
5.1
4.0
mg/mmol
4.1
8.6
2.50
111
897
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
75
2.03
1.71
1.3
1.1
—
—
—
0
0
(44813793)
7
25
2.82
1.65
1.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
25
2.82
1.65
3.7
2.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
18
98
1.86
1.63
1.3
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
10
43
2.35
1.61
3.4
3.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
15
77
1.97
1.60
1.7
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
495
4736
1.33
1.57
26.5
16.1
mmol/l
4.0
4.0
0.48
484
4606
(3024928) Oxygen saturation in Venous blood
18
100
1.83
1.54
4.3
2.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
20
115
1.77
1.54
1.6
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
23
138
1.69
1.54
3.2
3.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
124
1024
1.27
1.53
7.0
4.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
15
3.35
1.52
3.6
5.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
27
2.61
1.52
2.0
2.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
16
86
1.89
1.51
1.3
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
51
2.18
1.51
1.7
1.6
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
11
51
2.18
1.51
1.1
1.4
%
44.6
63.5
0.82
11
44
(3019550) Sodium [Moles/volume] in Serum or Plasma
493
4720
1.32
1.51
26.0
16.0
mmol/l
139.5
139.7
1.08
485
4597
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
65
2.02
1.49
1.7
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
16
87
1.86
1.47
2.3
2.1
%
15.3
16.6
—
9
42
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
38
2.39
1.46
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
38
2.39
1.46
1.2
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
28
2.52
1.45
1.4
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
48
347
1.42
1.44
5.9
4.1
%
0.3
0.5
0.73
14
89
(3000093) Morphology [Interpretation] in Blood Narrative
9
39
2.33
1.43
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
39
2.33
1.43
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
39
2.33
1.43
1.2
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
74
1.91
1.40
4.1
2.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
41
290
1.45
1.39
1.2
1.2
iu/ml
147.6
149.9
0.01
21
118
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
39
274
1.45
1.37
1.9
1.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
23
2.63
1.37
1.5
1.7
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
17
2.96
1.36
6.8
3.2
u/l
200.6
209.6
—
5
17
(21494890) Protein electrophoresis panel - 24 hour Urine
10
47
2.15
1.34
2.4
3.2
—
—
—
0
0
(3000012) Reticulocyte production index
6
24
2.52
1.30
1.5
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
24
2.52
1.30
1.5
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
51
381
1.37
1.29
4.6
3.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
18
2.79
1.28
1.4
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
38
270
1.44
1.27
1.2
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
28
188
1.51
1.23
1.9
1.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
12
63
1.92
1.23
2.8
2.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
14
78
1.81
1.22
1.1
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
36
256
1.43
1.21
17.9
9.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
26
2.32
1.19
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
26
2.32
1.19
1.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
64
1.89
1.18
1.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
501
4838
1.28
1.18
20.3
13.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
11
57
1.95
1.17
1.4
1.4
nmol/l
0.6
0.5
0.16
11
52
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
11
57
1.95
1.17
1.9
1.8
ug/l
31.3
16.7
0.43
11
57
(36660697) Celiac disease serology panel - Serum
47
353
1.36
1.16
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
77
621
1.28
1.16
1.2
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
20
2.51
1.15
1.0
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
455
4355
1.22
1.12
20.1
12.8
ml/min/173m2
84.1
82.2
1.02
392
3599
(3044927) Protein electrophoresis panel - Urine
10
51
1.98
1.11
1.2
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
18
112
1.63
1.10
1.8
1.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
21
2.39
1.09
3.2
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
142
1236
1.20
1.07
5.8
3.7
estimate
0.0
0.0
0.69
50
420
(3000494) Fungus identified in Specimen by Culture
69
557
1.27
1.05
1.7
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
34
2.07
1.03
1.4
1.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
9
47
1.93
1.02
1.3
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
53
1.90
1.02
1.4
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
115
1.58
1.00
3.4
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
67
543
1.26
0.99
7.9
7.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
49
1.85
0.99
1.3
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
49
1.85
0.99
1.3
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
49
1.85
0.99
1.3
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
23
2.18
0.98
1.4
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
23
2.18
0.98
1.4
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
199
1797
1.16
0.97
5.4
4.9
ug/l
2.2
3.0
0.60
179
1619
(3007566) Smooth muscle Ab [Titer] in Serum
19
125
1.54
0.95
1.2
1.2
—
94.0
—
0
10
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
85
1.66
0.95
2.3
1.6
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
28
2.15
0.91
1.0
4.0
nmol/l
65.8
87.1
—
6
28
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
86
1.64
0.91
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
314
2941
1.15
0.91
3.0
3.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
29
2.08
0.89
1.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
71
1.70
0.89
1.3
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
14
87
1.62
0.88
2.4
2.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
89
756
1.21
0.88
1.2
1.3
u/ml
8.1
11.6
0.38
29
296
(3020891) Body temperature
25
178
1.42
0.87
9.2
4.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
43
1.87
0.87
1.1
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
11
64
1.73
0.86
1.8
3.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
44
1.83
0.86
1.3
1.5
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
8
44
1.83
0.86
1.5
1.2
nmol/l
0.9
1.5
—
8
39
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
72
1.68
0.85
1.3
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
72
1.68
0.85
1.3
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
72
1.68
0.85
1.3
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
72
1.68
0.85
1.3
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
80
1.64
0.85
5.6
3.2
e9/l
4.3
4.4
0.08
13
80
(3048929) Epstein Barr virus Ab [Presence] in Serum
22
155
1.44
0.82
1.3
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
73
1.66
0.82
1.3
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
151
1678
0.86
0.81
3.1
2.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
48
1.68
0.79
3.0
1.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
15
99
1.53
0.76
5.5
3.8
mg/l
31.3
24.1
—
8
65
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
13
83
1.58
0.75
6.4
3.7
%
58.9
56.9
0.20
13
83
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
24
2.09
0.74
1.6
1.5
g/l
1.4
1.0
—
5
24
(4010399)
41
327
1.27
0.73
1.3
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
25
2.01
0.73
1.0
3.3
—
—
—
0
0
(4024509)
7
39
1.80
0.72
2.6
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
9
57
1.59
0.71
1.2
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
26
1.93
0.70
1.8
1.8
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.70
1.0
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
5
26
1.93
0.70
1.2
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.70
1.0
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
26
1.93
0.70
1.8
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
191
1755
1.13
0.70
5.6
3.6
—
—
—
0
0
(3013512) EKG study
146
1320
1.14
0.69
4.4
3.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
42
1.67
0.68
1.1
1.0
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
28
214
1.32
0.68
3.7
2.3
%
0.7
0.6
0.02
28
208
(3035880) pH of Pleural fluid
5
28
1.79
0.66
1.0
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
5
28
1.79
0.66
1.0
1.5
u/field
3.4
2.3
—
5
21
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
30
233
1.30
0.66
2.3
2.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
113
1008
1.15
0.65
5.5
3.8
kg/l
1.0
1.0
0.41
18
145
(3028626) Oxygen [Partial pressure] in Capillary blood
16
112
1.44
0.64
3.3
2.7
kpa
8.6
8.3
0.34
16
100
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.0
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.0
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.0
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
50
1.61
0.61
1.4
1.4
nmol/l
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
50
1.61
0.61
1.3
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
157
1438
1.13
0.61
4.2
4.3
%
21.1
21.3
0.06
74
685
(3025130) Human papilloma virus identified in Specimen
8
51
1.58
0.60
1.3
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
52
1.55
0.59
1.1
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
69
598
1.17
0.58
1.8
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
13
184
0.70
0.57
3.5
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
54
1.49
0.57
2.9
4.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
40
481
0.82
0.56
2.4
4.4
ug/l
84.0
30.3
0.35
26
409
(3027008) Opiates [Presence] in Urine
13
183
0.70
0.56
3.5
1.5
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
9
60
1.51
0.54
1.2
1.5
g/l
23.0
33.8
—
9
52
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
39
1.54
0.53
1.2
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
117
1.38
0.52
1.1
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
40
1.51
0.51
1.2
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
13
92
1.42
0.51
1.5
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
13
92
1.42
0.51
1.5
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
17
127
1.35
0.50
4.5
3.6
mg/l
1.6
1.5
0.10
17
117
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
136
1.33
0.49
1.7
1.4
ug/g
218.1
290.0
—
9
76
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
426
4370
0.90
0.48
4.3
3.9
mmol/l
1.4
1.3
2.81
379
4047
(3047352) Trisomy 18 risk [Likelihood] in Fetus
13
93
1.41
0.48
1.5
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
40
471
0.84
0.47
1.3
1.4
—
—
—
0
0
(4268621)
7
48
1.46
0.47
1.7
2.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
27
219
1.24
0.46
1.1
1.1
titre
—
95.9
—
0
7
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
48
415
1.17
0.44
1.5
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
7
51
1.38
0.44
1.0
1.1
u/ml
—
4.8
—
0
12
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
95
1.38
0.44
1.5
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
14
184
0.75
0.42
3.3
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
57
1.41
0.42
2.3
2.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
33
1.52
0.41
2.2
3.1
u/ml
14.4
64.5
—
5
33
(3020650) Glucose [Presence] in Urine
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
1.0
—
0
8
(3043410) Blood group antigens tested for on Red Blood Cells
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
114
1.32
0.41
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
114
1.32
0.41
1.3
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
17
132
1.30
0.40
1.6
2.3
u/l
5941.5
3259.5
—
6
50
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
60
1.34
0.40
1.6
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
18
0.00
0.40
0.0
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
14
182
0.76
0.40
3.3
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
103
0.68
0.40
1.1
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
135
1258
1.10
0.39
5.1
3.1
—
—
—
0
0
(3036603) Volume of Urine
5
35
1.43
0.39
1.2
1.7
—
1682.9
—
0
7
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
115
1.31
0.39
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
115
1.31
0.39
1.3
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
68
1.33
0.37
1.1
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
113
0.70
0.37
1.5
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
13
169
0.76
0.37
3.5
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
113
1048
1.10
0.36
3.4
2.9
ug/l
0.7
0.8
0.31
76
684
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
457
4651
0.91
0.35
5.0
4.8
mmol/l
2.7
2.7
0.36
407
4306
(3045788) Cell count panel - Pleural fluid
6
42
1.43
0.35
1.2
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
17
135
1.27
0.35
1.8
1.4
miu/ml
363.1
276.9
—
7
64
(3048689) Calprotectin [Mass/mass] in Stool
62
558
1.12
0.35
2.1
2.3
ug/g
172.6
126.5
0.48
47
441
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
163
1.24
0.34
1.5
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
45
1.34
0.34
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
88
0.68
0.33
1.7
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
447
4549
0.92
0.33
4.7
4.3
mmol/l
1.4
1.4
2.11
398
4219
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
55
494
1.13
0.32
2.1
2.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
47
1.28
0.32
1.2
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
432
4240
1.08
0.30
6.6
5.6
mmol/mol
40.9
39.8
1.17
390
3955
(3022145) Colonoscopy Study observation
59
535
1.11
0.30
1.3
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
75
1.34
0.30
1.0
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
499
4926
1.10
0.30
14.6
10.3
u/l
29.0
27.3
0.95
482
4772
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
56
508
1.11
0.29
2.0
1.7
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
57
1.23
0.29
1.3
3.5
nmol/l
3.0
3.7
—
7
57
(4306422)
7
57
1.23
0.29
1.1
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
121
1.25
0.28
1.5
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
60
547
1.11
0.28
2.4
2.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
65
1.23
0.27
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
450
4567
0.93
0.26
4.6
4.4
mmol/l
4.6
4.6
0.28
404
4261
(3003740) Influenza virus B Ag [Presence] in Specimen
9
75
1.20
0.25
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
126
0.79
0.24
5.1
4.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
18
152
1.19
0.24
14.3
6.3
mmol/l
1.3
1.3
0.14
18
135
(3011288) Drugs identified in Urine by Screen method
14
115
1.22
0.23
4.1
2.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
5
38
1.32
0.23
1.0
1.0
—
1.5
—
0
10
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
38
1.32
0.23
1.2
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
5
38
1.32
0.23
1.0
1.3
%
36.6
26.2
—
5
30
(3000330) Specific gravity of Urine by Test strip
20
231
0.86
0.22
3.9
3.2
—
—
—
0
0
(4034850)
13
156
0.83
0.21
19.3
11.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
12
0.00
0.21
0.0
2.9
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
12
0.00
0.21
0.0
5.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
104
0.77
0.21
2.6
2.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
5
43
1.16
0.21
1.0
1.3
ug/l
1.9
3.2
—
5
37
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
3.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
10
80
1.25
0.20
3.8
1.8
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(4035726)
43
394
1.10
0.20
1.3
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
53
1.13
0.18
3.0
3.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
62
1.13
0.17
1.3
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
63
1.11
0.17
1.1
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
7
63
1.11
0.17
8.0
4.9
umol/l
385.6
366.1
—
7
55
(40761536) Microorganisms panel - Urine sediment
42
392
1.08
0.14
6.9
3.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
118
0.84
0.14
1.2
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
26
284
0.91
0.13
1.3
1.4
—
—
—
0
0
(1002224) Polysomnography panel
19
210
0.90
0.12
1.1
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
326
3217
1.03
0.12
3.9
3.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
123
1265
0.96
0.11
1.7
1.7
mmol/l
1.4
1.4
0.09
95
1062
(3022217) INR in Platelet poor plasma by Coagulation assay
61
583
1.05
0.11
23.6
24.4
inr
1.3
1.3
—
8
78
(3039000) Anion gap in Blood
13
115
1.13
0.10
17.2
6.6
mmol/l
10.6
11.5
0.73
13
105
(3018572) Chloride [Moles/volume] in Blood
13
115
1.13
0.10
17.2
6.6
mmol/l
105.1
105.2
0.02
13
105
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24
222
1.08
0.10
2.2
2.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
84
812
1.04
0.10
2.7
2.9
mmol/l
2.5
2.4
0.37
77
710
(3002256) Pathology report gross observation
61
585
1.05
0.10
1.5
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
164
1.10
0.10
2.6
1.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
46
1.09
0.09
1.2
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
40
421
0.95
0.09
1.7
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
20
184
1.09
0.09
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
125
1280
0.97
0.09
1.6
1.4
—
—
—
0
0
(4094501)
14
126
1.11
0.09
1.2
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
15
136
1.11
0.08
1.4
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
23
214
1.08
0.08
3.0
2.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
117
1.11
0.08
1.8
1.5
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
7
64
1.09
0.08
1.0
1.1
g/l
2.1
1.5
—
7
59
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
66
1.06
0.08
1.1
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
38
362
1.05
0.08
3.1
2.8
ml/min/173m2
64.7
68.3
0.25
17
157
(3007461) Platelets [#/volume] in Blood
518
5160
1.04
0.07
33.0
20.5
e9/l
248.0
247.2
0.11
505
5043
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
20
186
1.08
0.07
1.3
1.9
mg/l
2.8
2.6
0.10
15
134
(3045424) Erythrocytes [Presence] in Urine
9
84
1.07
0.07
1.1
1.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
518
5163
1.03
0.06
32.8
20.4
pg
30.3
30.4
0.16
510
5096
(3026361) Erythrocytes [#/volume] in Blood
518
5164
1.03
0.05
33.0
20.5
e12/l
4.4
4.5
3.15
502
5034
(3010813) Leukocytes [#/volume] in Blood
518
5164
1.03
0.05
33.0
20.5
e9/l
6.9
6.7
0.81
503
5032
(3024731) MCV [Entitic volume]
518
5164
1.03
0.05
32.8
20.4
fl
91.1
91.0
0.25
510
5098
(3022621) pH of Urine by Test strip
32
308
1.04
0.04
3.0
2.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
518
5166
1.03
0.04
33.2
20.6
g/l
134.1
136.5
2.69
509
5094
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
444
4456
0.98
0.04
5.0
4.4
mmol/l
6.1
5.9
0.75
392
4092
(3000492) Spirometry study
45
461
0.97
0.03
1.7
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
138
0.94
0.02
5.6
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
20
192
1.04
0.02
1.8
3.1
u/ml
9.8
981.9
0.74
14
165
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
22
228
0.96
0.02
1.0
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
388
3890
0.99
0.01
27.8
16.9
%
13.8
13.7
0.81
382
3828
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
28
273
1.03
0.01
2.2
2.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
79
797
0.99
0.01
1.7
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
116
1.04
0.00
2.3
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
20
195
1.03
0.00
11.7
5.2
%
1.5
1.6
0.20
20
183
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
20
195
1.03
0.00
1.6
1.5
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
19
194
0.98
0.00
12.2
5.2
%
1.0
0.9
0.46
19
182
(40768800) Prostate Pathology biopsy report
11
113
0.97
0.00
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
23
226
1.02
0.00
1.9
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
13
132
0.98
0.00
1.4
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
21
208
1.01
0.00
1.8
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
425
4251
1.00
0.00
24.6
14.8
%
39.3
40.1
1.02
292
3118
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
8
89
0.90
0.00
1.5
1.2
u/l
10.5
34.5
—
8
77
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
55
0.91
0.00
1.2
1.7
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
4.7
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
9
0.00
0.00
0.0
6.0
—
7.4
—
0
9
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
19.2
—
0
6
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
66
0.91
0.00
1.0
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
67
0.89
0.00
2.0
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
73
0.96
0.00
2.0
1.6
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.1
—
82.8
—
0
9
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
1.6
—
38.2
—
0
5
(3025315) Body weight
0
5
0.00
-0.00
0.0
3.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
1.4
—
1.6
—
0
5
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_GUILBAR and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_GUILBAR | 2.186 [1.81, 2.63] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.473 |
During the follow-up period (1.1.1998 — 31.12.2019), 256 out of 1332 females with G6_GUILBAR died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_GUILBAR | 1.876 [1.59, 2.21] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 391 out of 1622 males with G6_GUILBAR died.
Mortality risk
Mortality risk for people of age
years, who have G6_GUILBAR.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.24% | 0.382% |
| 5 | 1.313% | 1.977% |
| 10 | 3.35% | 4.535% |
| 15 | 6.366% | 8.683% |
| 20 | 11.367% | 14.611% |
Relationships between endpoints
↥Index endpoint: G6_GUILBAR – Guillain-Barre syndrome
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data